Abbott Laboratories (ABT)

ABT (NYSE:Health Services)
neg -0.80
Today's Range: 41.48 - 43.03 | ABT Avg Daily Volume: 4,529,600
Last Update: 10/22/14 - 4:00 PM EDT
Volume: 6,986,395
YTD Performance: 10.59%
Open: $42.50
Previous Close: $42.39
52 Week Range: $35.65 - $44.20
Oustanding Shares: 1,503,699,033
Market Cap: 62,343,361,908
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 4 3 3 3
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.84 1.83 1.83 1.83
Latest Dividend: 0.22
Latest Dividend Yield: 2.06%
Dividend Ex-Date: 10/10/14
Price Earnings Ratio: 30.96
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
30.96 27.30 27.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.33% 15.00% 57.41%
Revenue -45.20 -0.38 -0.15
Net Income -56.80 -0.48 -0.20
EPS -56.80 -0.45 -0.18
Earnings for ABT:
Revenue 21.85B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.60 $0.69 $2.25 $2.50
Number of Analysts 10 8 10 9
High Estimate $0.62 $0.71 $2.29 $2.57
Low Estimate $0.58 $0.67 $2.22 $2.40
Prior Year $0.55 $0.58 $2.01 $2.25
Growth Rate (Year over Year) 8.91% 19.83% 11.84% 11.16%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
I really like a couple of names despite the uncertainty.
There may be a wave of consolidation.
And don't try to catch every move.
Jul 21, 2014 | 7:59 AM EDT
ABT 2015E-2018E EPS estimates lowered 7-10%, Jefferies said. Buy rating. Estimates reflect the divestiture of the developed market EPD ...

This Morning's Market Setup Real Money Pro($)

Where it began.
May 19, 2014 | 8:18 AM EDT
ABT was upgraded from Neutral to Outperform, Credit Suisse said. $46 price target. Company is more attractive, following the CFR acquis...
May 08, 2014 | 7:08 AM EDT
Deutsche Bank Healthcare Conference
Mar 19, 2014 | 7:29 AM EDT
ABT lowered its number, Jefferies said. Pricing pressure in EPD, MD pricing/volume pressurse and FX exposure. $45 price target. Buy rat...
Feb 12, 2014 | 8:02 AM EST
Shares of ABT dropped to $46, according to Jefferies. Pricing pressure in EPS and FX exposure. Buy rating. 
Great investors and great quarterbacks have a lot in common.

Columnist Conversations

CHECK IT OUT HERE Lot's of great out and underperformer picks, as well as M&A ideas that you don't always ...
The major market indices continue to move within the parameters of the Fibonacci retracement levels measured o...
Since we cleared a key decision on the way up, I want to watch this pullback for an entry if it fires off a bu...
Conclusion DDD is down today on new that the firm has cut revenue forecast due to production issues. The issue...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.